Market Cap (In CNY)
496.62 Million
Revenue (In CNY)
86.62 Million
Net Income (In CNY)
-70.94 Million
Avg. Volume
11.07 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.43-11.5
- PE
- -9.54
- EPS
- -0.13
- Beta Value
- 0.393
- ISIN
- CNE1000021X8
- CUSIP
- -
- CIK
- -
- Shares
- 400500000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Ya He Li
- Employee Count
- -
- Website
- https://www.longjin.com.cn
- Ipo Date
- 2015-03-24
- Details
- Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. It also engages in the industrial hemp plantation business. The company was founded in 1996 and is headquartered in Kunming, China.
More Stocks
-
MGAAFMorinaga&Co., Ltd.
MGAAF
-
301129
-
ARRNF
-
DIAMONDYDPrataap Snacks Limited
DIAMONDYD
-
CLS
-
JYOTHYLABJyothy Labs Limited
JYOTHYLAB
-
KTYCFKits Eyecare Ltd.
KTYCF
-
0J86